Published in J Allergy Clin Immunol on December 01, 1989
Regulation of high-affinity IgE receptor-mediated mast cell activation by murine low-affinity IgG receptors. J Clin Invest (1995) 1.70
Fc gamma receptors in respiratory syncytial virus infections: implications for innate immunity. Rev Med Virol (2013) 0.76
Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med (1989) 10.60
Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J Exp Med (1991) 7.52
Response of resting human peripheral blood natural killer cells to interleukin 2. J Exp Med (1984) 5.26
Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor functions. I. Characterization of the lymphocyte subset reactive with B73.1. J Immunol (1983) 4.94
Independent regulation of tumor necrosis factor and lymphotoxin production by human peripheral blood lymphocytes. J Exp Med (1987) 4.54
Alternative membrane forms of Fc gamma RIII(CD16) on human natural killer cells and neutrophils. Cell type-specific expression of two genes that differ in single nucleotide substitutions. J Exp Med (1989) 3.36
Human natural killer cells: biologic and pathologic aspects. Lab Invest (1984) 2.99
Immune interferon induces the receptor for monomeric IgG1 on human monocytic and myeloid cells. J Exp Med (1983) 2.93
Interaction of Fc receptor (CD16) ligands induces transcription of interleukin 2 receptor (CD25) and lymphokine genes and expression of their products in human natural killer cells. J Exp Med (1988) 2.79
Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients. J Exp Med (1992) 2.71
The Fc receptor for IgG on human natural killer cells: phenotypic, functional, and comparative studies with monoclonal antibodies. J Immunol (1984) 2.70
Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor functions. II. Studies of B73.1 antibody-antigen interaction on the lymphocyte membrane. J Immunol (1983) 2.37
Immune interferon enhances functional properties of human granulocytes: role of Fc receptors and effect of lymphotoxin, tumor necrosis factor, and granulocyte-macrophage colony-stimulating factor. J Immunol (1987) 2.24
Tumor necrosis factor and lymphotoxin induce differentiation of human myeloid cell lines in synergy with immune interferon. J Exp Med (1986) 2.23
A leukocyte subset bearing HLA-DR antigens is responsible for in vitro alpha interferon production in response to viruses. Nat Immun Cell Growth Regul (1985) 2.17
Natural killer (NK) cell-derived hematopoietic colony-inhibiting activity and NK cytotoxic factor. Relationship with tumor necrosis factor and synergism with immune interferon. J Exp Med (1985) 2.11
A human NK and K cell subset shares with cytotoxic T cells expression of the antigen recognized by antibody OKT8. J Immunol (1983) 2.04
Natural killer (NK) cell-mediated cytotoxicity: differential use of TRAIL and Fas ligand by immature and mature primary human NK cells. J Exp Med (1998) 2.03
Double-stranded RNA unwinding and modifying activity is detected ubiquitously in primary tissues and cell lines. Mol Cell Biol (1990) 1.89
Mechanisms of IFN-gamma induction by natural killer cell stimulatory factor (NKSF/IL-12). Role of transcription and mRNA stability in the synergistic interaction between NKSF and IL-2. J Immunol (1992) 1.88
Final steps of natural killer cell maturation: a model for type 1-type 2 differentiation? Nat Immunol (2001) 1.85
Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells. J Immunol (2001) 1.76
Induction of proliferation in vitro of resting human natural killer cells: IL 2 induces into cell cycle most peripheral blood NK cells, but only a minor subset of low density T cells. J Immunol (1986) 1.75
Antibody 3G8, specific for the human neutrophil Fc receptor, reacts with natural killer cells. J Immunol (1984) 1.75
Tumor necrosis factor and immune interferon synergistically induce cytochrome b-245 heavy-chain gene expression and nicotinamide-adenine dinucleotide phosphate hydrogenase oxidase in human leukemic myeloid cells. J Clin Invest (1989) 1.73
Interferon production by human and murine lymphocytes in response to alloantigens. J Immunol (1980) 1.70
Immune interferon and leukocyte-conditioned medium induce normal and leukemic myeloid cells to differentiate along the monocytic pathway. J Exp Med (1983) 1.69
Phosphatidylinositol-3 kinase activity is regulated by BCR/ABL and is required for the growth of Philadelphia chromosome-positive cells. Blood (1995) 1.69
Activation of basophil and mast cell histamine release by eosinophil granule major basic protein. J Exp Med (1983) 1.69
Production of hematopoietic colony-stimulating factors by human natural killer cells. J Exp Med (1989) 1.67
Requirement for HLA-DR+ accessory cells in natural killing of cytomegalovirus-infected fibroblasts. J Exp Med (1986) 1.63
Induction of proliferation in vitro of resting human natural killer cells: expression of surface activation antigens. J Immunol (1985) 1.58
Simultaneous activation of NADPH oxidase-related proton and electron currents in human neutrophils. Proc Natl Acad Sci U S A (2000) 1.58
Monoclonal antibodies that detect differentiation surface antigens on human myelomonocytic cells. Blood (1982) 1.57
The cytotoxic effector cells in preparations of adherent mononuclear cells from human peripheral blood. J Immunol (1984) 1.50
Stimulus-specific regulation of chemokine expression involves differential activation of the redox-responsive transcription factors AP-1 and NF-kappaB. J Leukoc Biol (1999) 1.49
Interactions between NADPH oxidase-related proton and electron currents in human eosinophils. J Physiol (2001) 1.46
Exposure of platelet fibrinogen-binding sites by collagen, arachidonic acid, and ADP: inhibition by a monoclonal antibody to the glycoprotein IIb-IIIa complex. Blood (1983) 1.44
Activation and expression of the nuclear factors of activated T cells, NFATp and NFATc, in human natural killer cells: regulation upon CD16 ligand binding. J Exp Med (1995) 1.43
Identification and characterization of a pore-forming protein of human peripheral blood natural killer cells. J Exp Med (1986) 1.41
Stimulation of Fc gamma RIIIA results in phospholipase C-gamma 1 tyrosine phosphorylation and p56lck activation. J Exp Med (1992) 1.41
Dependence of both spontaneous and antibody-dependent, granule exocytosis-mediated NK cell cytotoxicity on extracellular signal-regulated kinases. J Immunol (1998) 1.40
Purification of cardiac myosin. Application to hypertrophied myocardium. Biochim Biophys Acta (1975) 1.37
Stimulation of basophil and rat mast cell histamine release by eosinophil granule-derived cationic proteins. J Immunol (1984) 1.35
Enhancing effect of natural killer cell stimulatory factor (NKSF/interleukin-12) on cell-mediated cytotoxicity against tumor-derived and virus-infected cells. Eur J Immunol (1993) 1.32
Modulation of perforin and granzyme messenger RNA expression in human natural killer cells. J Immunol (1993) 1.31
Terminal differentiation surface antigens of myelomonocytic cells are expressed in human promyelocytic leukemia cells (HL60) treated with chemical inducers. Blood (1981) 1.30
Fc gamma R-dependent mitogen-activated protein kinase activation in leukocytes: a common signal transduction event necessary for expression of TNF-alpha and early activation genes. J Exp Med (1996) 1.25
Eosinophil granule proteins in peripheral blood granulocytes. J Leukoc Biol (1992) 1.24
Activation of NADPH oxidase-related proton and electron currents in human eosinophils by arachidonic acid. J Physiol (2001) 1.24
Differential role of p38 and c-Jun N-terminal kinase 1 mitogen-activated protein kinases in NK cell cytotoxicity. J Immunol (2000) 1.23
Physical and functional association of p56lck with Fc gamma RIIIA (CD16) in natural killer cells. J Exp Med (1993) 1.23
The SH3 domain contributes to BCR/ABL-dependent leukemogenesis in vivo: role in adhesion, invasion, and homing. Blood (1998) 1.20
The role of agonists that activate adenylate cyclase in the control of cAMP metabolism and enzyme release by human polymorphonuclear leukocytes. J Immunol (1980) 1.19
Functional studies of Fc receptor-bearing human lymphocytes: effect of treatment with proteolytic enzymes. J Immunol (1979) 1.19
Differential transcriptional regulation of CD161 and a novel gene, 197/15a, by IL-2, IL-15, and IL-12 in NK and T cells. J Immunol (1998) 1.19
Inhibition of bone marrow colony formation by human natural killer cells and by natural killer cell-derived colony-inhibiting activity. J Exp Med (1985) 1.19
Phorbol esters enhance spontaneous cytotoxicity of human lymphocytes, abrogate Fc receptor expression, and inhibit antibody-dependent lymphocyte-mediated cytotoxicity. J Immunol (1984) 1.18
Effects of recombinant tumor necrosis factor, lymphotoxin, and immune interferon on proliferation and differentiation of enriched hematopoietic precursor cells. Exp Hematol (1988) 1.14
Resistance of cytolytic lymphocytes to perforin-mediated killing. Lack of correlation with complement-associated homologous species restriction. J Exp Med (1988) 1.13
Correlation between differentiation, expression of monocyte-specific antigens, and cytotoxic functions in human promyelocytic cell lines treated with leukocyte-conditioned medium. J Immunol (1983) 1.10
Listeria monocytogenes phosphatidylinositol (PI)-specific phospholipase C has low activity on glycosyl-PI-anchored proteins. J Bacteriol (1993) 1.10
Cytotoxic activity and interferon production by lymphocytes from patients with multiple sclerosis. J Immunol (1981) 1.09
Phosphatidylinositol-3 kinase activation induced upon Fc gamma RIIIA-ligand interaction. J Exp Med (1994) 1.08
Definition of a natural killer NKR-P1A+/CD56-/CD16- functionally immature human NK cell subset that differentiates in vitro in the presence of interleukin 12. J Exp Med (1996) 1.08
In vitro infection of natural killer cells with different human immunodeficiency virus type 1 isolates. J Virol (1991) 1.08
Interferon-induced resistance of fibroblasts to cytolysis mediated by natural killer cells: specificity and mechanism. J Immunol (1981) 1.06
Negative regulation of p120GAP GTPase promoting activity by p210bcr/abl: implication for RAS-dependent Philadelphia chromosome positive cell growth. J Exp Med (1994) 1.06
Donor leukocyte infusions are effective in relapsed multiple myeloma after allogeneic bone marrow transplantation. Blood (1997) 1.05
Differentially regulated expression of the G-protein-coupled receptor kinases, betaARK and GRK6, during myelomonocytic cell development in vitro. Blood (1996) 1.03
Noncytotoxic activation of neutrophils by eosinophil granule major basic protein. Effect on superoxide anion generation and lysosomal enzyme release. J Immunol (1990) 1.02
Inactivation of natural killer cell cytotoxic activity after interaction with target cells. J Immunol (1981) 1.01
Quantitative endotoxin determination in blood with a chromogenic substrate. Clin Chim Acta (1981) 1.01
Dendritic cells and IFN-alpha-producing cells are two functionally distinct non-B, non-monocytic HLA-DR+ cell subsets in human peripheral blood. Immunology (1989) 0.98
Stimulation and proliferation of CD4+ peripheral blood T lymphocytes induced by an anti-CD4 monoclonal antibody. Eur J Immunol (1988) 0.98
Role of immune interferon in the monocytic differentiation of human promyelocytic cell lines induced by leukocyte conditioned medium. Blood (1985) 0.97
A novel and highly divergent homolog of human eosinophil granule major basic protein. J Biol Chem (1999) 0.96
C-RAF-1 serine/threonine kinase is required in BCR/ABL-dependent and normal hematopoiesis. Cancer Res (1995) 0.96
Signaling for cytotoxicity. Nat Immunol (2000) 0.95
High school students' long-term retention of sex education information. J Sch Health (1985) 0.94
Binding of platelets to human monocytes: a source of artifacts in the study of the specificity of antileukocyte antibodies. J Immunol Methods (1982) 0.94
Immune interferon: a pleiotropic lymphokine with multiple effects. Immunol Today (1985) 0.94
Methylxanthine bronchodilators potentiate multiple human neutrophil functions. J Immunol (1987) 0.94
Sarcoidosis associated with autoimmune thrombocytopenia and selective IgA deficiency. Scand J Haematol (1982) 0.93
Low-intensity oral anticoagulation in sickle-cell disease reverses the prethrombotic state: promises for treatment? Br J Haematol (1995) 0.92
The emerging role of IL-15 in NK-cell development. Immunol Today (2000) 0.90
Ligand binding to Fc gamma R induces c-myc-dependent apoptosis in IL-2-stimulated NK cells. J Immunol (1995) 0.90
Membrane proteins on human megakaryocytes and platelets identified by monoclonal antibodies. Am J Hematol (1983) 0.89
Endotoxin testing in blood. Prog Clin Biol Res (1987) 0.88
Analysis of signaling events associated with activation of neutrophil superoxide anion production by eosinophil granule major basic protein. Blood (1995) 0.88
Antagonistic effects of interferons on the cytotoxicity mediated by natural killer cells. Fed Proc (1981) 0.87
Regulation of hematopoiesis by T lymphocytes and natural killer cells. Crit Rev Oncol Hematol (1987) 0.87
The role of basophils in inflammatory reactions. J Invest Dermatol (1978) 0.87
The anti-inflammatory actions of tilorone hydrochloride. Proc Soc Exp Biol Med (1975) 0.87
Surface expression of lactoferrin by resting neutrophils. Biochem Biophys Res Commun (2000) 0.86
Interferon modulation of natural killer cell activity. Ann N Y Acad Sci (1980) 0.85
Comparative investigation of a quantitative chromogenic endotoxin assay and blood cultures. Am J Clin Pathol (1984) 0.84
Cyclic nucleotides in immune responses and allergy. Adv Cyclic Nucleotide Res (1980) 0.84
Functional integrity of the SH1 site in myosin from hypertrophied myocardium. Biochim Biophys Acta (1977) 0.84